The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Case Report: When Moyamoya Disease Mimicks Primary Central Nervous System Vasculitis

Rheumatology Case Report: When Moyamoya Disease Mimicks Primary Central Nervous System Vasculitis

November 16, 2015 • By Joey Kim, MD, Megha Patel-Banker, MD, Matthew Abramson, MD, Mehwish Bilal, MD, Sanjay Godhwani, MD, Asha Patnaik, MD, Heidi Roppelt, MD, & Qingping Yao, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Figure 1: A head CT revealed a subacute infarct involving the right-posterior medial, parietal and occipital lobes.

Figure 1: A head CT revealed a subacute infarct involving the right-posterior medial, parietal and occipital lobes.

Case report: A 60-year-old Hispanic male with poorly controlled hypertension was sent from the primary care clinic for evaluation of malignant hypertension with a systolic blood pressure above 200 mmHg. His symptoms at the time of presentation included episodic confusion, worsening vision and an unsteady gait.

You Might Also Like
  • Case Report: Lymphocytic Vasculitis of the Central Nervous System
  • Rheumatic Disease Manifestations in the Central Nervous System
  • Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?
Explore This Issue
November 2015

A head computed tomography (CT) scan showed a subacute infarct involving the right posterior medial, parietal and occipital lobes (see Figure 1).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A magnetic resonance imaging (MRI) and magnetic resonance angiogram (MRA) scan were performed. They demonstrated bilateral middle cerebral artery (MCA) stenosis with good collateral circulation and confirmed a subacute right occipito-parietal infarct, involving the splenium (see Figures 2A & 2B).

A CT cerebral angiogram was performed and showed near occlusion of the distal right middle cerebral artery, occlusion of the proximal left MCA and occlusion of the right posterior cerebral artery (see Figure 3).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The patient was started on aspirin, clopidogrel and atorvastatin. After a 14-day hospital course, the patient was discharged to home.

Two weeks later, the patient presented to the emergency department with a new-onset, right-sided facial droop and slurred speech. An MRI at this visit showed an acute lacunar infarct of the left corona radiata (see Figure 4). Despite normal erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), anti-neutrophil cytoplasmic antibody (ANCA) and antinuclear antibody (ANA) tests, there was a concern for CNS vasculitis, and the patient was empirically started on high-dose steroids.

Further workup included the following studies: immunoglobulin levels, complement levels, and cerebrospinal fluid (CSF) analysis for antibodies. All studies were negative. A repeat CT cerebral angiogram revealed long-segment stenosis of both MCAs (see Figures 5A & 5B). At this time, a diagnosis of moyamoya disease was made. The patient was started on warfarin (Coumadin) and discharged to home.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 2A: An MRI of the brain confirmed a subacute infarct involving the right occipito-parietal lobe.

Figure 2A: An MRI of the brain confirmed a subacute infarct involving the right occipito-parietal lobe.

Figure 2B: An MRA revealed the lack of flow in the middle cerebral artery that could be attributed to an occlusion or stenosis.

Figure 2B: An MRA revealed the lack of flow in the middle cerebral artery that could be attributed to an occlusion or stenosis.

Figure 3: A CT angiogram of the head revealed bilateral MCA stenoses and occlusion of the right posterior cerebral artery.

Figure 3: A CT angiogram of the head revealed bilateral MCA stenoses and occlusion of the right posterior cerebral artery.

Discussion

Primary CNS vasculitis, also known as primary angiitis of the CNS (PACNS), and moyamoya disease are both rare causes of stroke and are often indistinguishable in clinical presentation. Although both may present similarly, physicians must learn to differentiate between them, because management for each differs greatly.

For moyamoya disease, no evidence suggests any benefit from corticosteroid therapy.

PACNS is a rare vasculitis that is limited to the brain and the spinal cord. It leads to diverse and non-specific neurological manifestations, with an increase in morbidity and mortality.1

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Vasculitis Tagged With: case report, central nervous system, Diagnosis, moyamoya, patient care, rheumatology, Treatment, VasculitisIssue: November 2015

You Might Also Like:
  • Case Report: Lymphocytic Vasculitis of the Central Nervous System
  • Rheumatic Disease Manifestations in the Central Nervous System
  • Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?
  • Meet the Challenge of Primary CNS Vasculitis

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)